PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation.

MLA

Chelban, Viorica, et al. “PDXK Mutations Cause Polyneuropathy Responsive to Pyridoxal 5’-Phosphate Supplementation.” Annals of Neurology, vol. 86, no. 2, Aug. 2019, pp. 225–40. EBSCOhost, https://doi.org/10.1002/ana.25524.

APA

Chelban, V., Wilson, M. P., Warman Chardon, J., Vandrovcova, J., Zanetti, M. N., Zamba-Papanicolaou, E., Efthymiou, S., Pope, S., Conte, M. R., Abis, G., Liu, Y.-T., Tribollet, E., Haridy, N. A., Botía, J. A., Ryten, M., Nicolaou, P., Minaidou, A., Christodoulou, K., Kernohan, K. D., … Houlden, H. (2019). PDXK mutations cause polyneuropathy responsive to pyridoxal 5’-phosphate supplementation. Annals of Neurology, 86(2), 225–240. https://doi.org/10.1002/ana.25524

Chicago

Chelban, Viorica, Matthew P Wilson, Jodi Warman Chardon, Jana Vandrovcova, M Natalia Zanetti, Eleni Zamba-Papanicolaou, Stephanie Efthymiou, et al. 2019. “PDXK Mutations Cause Polyneuropathy Responsive to Pyridoxal 5’-Phosphate Supplementation.” Annals of Neurology 86 (2): 225–40. doi:10.1002/ana.25524.